4Arai Y,Hirose N,Yamamura K,et al.Long-term effect of lipid lowering tnerapy of a therosclerosis of abdominal aorta in patients with hypercho lesterolemia:noninvasive evaluation by a new image analysis program[J].Angiology,2002,53(1):57-68.
5Badimon JJ,Fuster V,Badimon L.role of high density lipoproteins in the regression for atherosclerosis[J].Circulation,1992,86(6):1186-1194.
3Todd J,Bruno,Mala T,et al.Development and validation of anoninvasive method to determine arterial pressure and vascular compliance[J].Am J Cardiol,1997,80:323-330.
4Cohn JN.Vascular wall function as a risk marker of cardiovasculardisease[J].J Hypertens,1999,17:41-44.
5Lisheng L,Wang JG.Systlic hypertension of china (SystChina)[J].Arch Int Med,2000,160:211 -220.
6Van Popele NM,Grobbee DE,Bots ML,et al.Association between arterial stiffness and atherosclerosis:the Rotterdam Study[J].Stroke,2001,32:454-460.
7Baetta R, Camera M, Camparato C, et al. Fluvastain reduees tissue factor expression and macrophage accumulation in carotid lesions of cholesterolled rabbits in the absense of lipid lowering [ J ]. Arterioscler Thromb Vasc Biol, 2002, 22:692-694.
